Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK/PD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00372957
What this trial is testing

Study Of GW823093 In Japanese Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 30
Early research (Phase 1)Study completedNCT03847207
What this trial is testing

A Study in Healthy Subjects to Assess the Safety, Tolerability, PK and PD of HTL0030310

Who this might be right for
Healthy
Nxera Pharma UK Limited 42
Testing effectiveness (Phase 2)Study completedNCT05549219
What this trial is testing

24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDG

Who this might be right for
Pmm2-CDGPhosphomannomutase 2 Deficiency
Glycomine, Inc. 27
Testing effectiveness (Phase 2)Ended earlyNCT03602261
What this trial is testing

Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI

Who this might be right for
Secondary Hyperparathyroidism Due to Renal CausesChronic Kidney DiseasesVitamin D Deficiency+1 more
OPKO Health, Inc. 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT04806854
What this trial is testing

PK and PD Study of LUM-201 in Children With Idiopathic Growth Hormone Deficiency: (OraGrowtH212)

Who this might be right for
Growth Hormone Deficiency
Lumos Pharma 24
Early research (Phase 1)Study completedNCT03490669
What this trial is testing

Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors

Who this might be right for
Advanced Solid TumorsPancreatic CancerNon Small Cell Lung Cancer+1 more
AstraZeneca 41
Early research (Phase 1)Study completedNCT00958477
What this trial is testing

Determine the Safety, Tolerability, Pharmacokinetics and Dynamic Effects of Different Doses of the Study Drug EMD 525797 in Prostate Cancer

Who this might be right for
Prostate CancerBone Metastases
Merck KGaA, Darmstadt, Germany 26
Testing effectiveness (Phase 2)Study completedNCT06010953
What this trial is testing

SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment

Who this might be right for
MaleHemophilia A With InhibitorHemophilia B With Inhibitor+1 more
Hangzhou Gensciences Biopharmaceutical Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT00247572
What this trial is testing

Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories

Who this might be right for
Attention Deficit Disorder With HyperactivityAmphetamine-Related DisordersSubstance-Related Disorders
New River Pharmaceuticals 12
Early research (Phase 1)Study completedNCT01433731
What this trial is testing

Safety, Pharmacodynamics (PD), Pharmacokinetics (PK) Study of SHP141 in 1A, 1B, or 2A Cutaneous T-Cell Lymphoma (CTCL)

Who this might be right for
Lymphoma, T-Cell, Cutaneous
TetraLogic Pharmaceuticals 18
Early research (Phase 1)Not Yet RecruitingNCT06055231
What this trial is testing

PK/PD of Vaping THC-containing Liquids vs. Smoked Cannabis

Who this might be right for
Cigarette Smoking-Related Carcinoma
Roswell Park Cancer Institute 40
Early research (Phase 1)Study completedNCT04155645
What this trial is testing

To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD8233 After Multiple Dose Administration in Subjects With Dyslipidemia

Who this might be right for
Dyslipidemia
AstraZeneca 34
Early research (Phase 1)Study completedNCT01106469
What this trial is testing

Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of Single and Multiple Ascending Doses of JNJ-41443532 in Healthy Male Participants

Who this might be right for
Healthy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 74
Testing effectiveness (Phase 2)Active Not RecruitingNCT05691361
What this trial is testing

Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema Patients

Who this might be right for
Hereditary Angioedema
ADARx Pharmaceuticals, Inc. 53
Early research (Phase 1)UnknownNCT02579473
What this trial is testing

Weekly Subcutaneous Injections of SER-214 in Subjects With Parkinson's Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetic (PK) Profile of SER-214

Who this might be right for
Parkinson's Disease
Serina Therapeutics 20
Testing effectiveness (Phase 2)Study completedNCT00778518
What this trial is testing

Safety, Tolerability and PK/PD Study in Young Adult Patients With Childhood Onset Growth Hormone Deficiency (GHD).

Who this might be right for
Growth Hormone Deficiency
Ambrx, Inc. 36
Early research (Phase 1)Study completedNCT02634515
What this trial is testing

Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics of Julphar Insulin R and Huminsulin® Normal

Who this might be right for
Diabetes Mellitus
Julphar Gulf Pharmaceutical Industries 26
Early research (Phase 1)Study completedNCT06548932
What this trial is testing

Evaluate the Safety, Tolerance, PK and PD Parameters of GZR33 and GZR101 in Healthy Male Adult Subjects

Who this might be right for
Healthy Subjects
Gan and Lee Pharmaceuticals, USA 52
Testing effectiveness (Phase 2)Study completedNCT06391593
What this trial is testing

PD, PK, and Safety of ALTO-203 in Patients With MDD

Who this might be right for
Major Depressive DisorderAnhedonia
Alto Neuroscience 69
Testing effectiveness (Phase 2)Study completedNCT02206100
What this trial is testing

PK and PD of Single, Escalating Doses of PER977 Following Enoxaparin

Who this might be right for
Healthy
Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. 40
Next Page